Topalian Suzanne Louise reported VIR

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001628280-26-067824

Machine-readable

Structured copy

Timestamps

Event (reported)

Oct 27, 2026

Published

Oct 28, 2026

Ingested by INSIDER

Nov 5, 02:09 UTC

Last re-read

Nov 5, 02:09 UTC

Extracted facts

Filer

Topalian Suzanne Louise

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Vir Biotechnology, Inc. — Stock Option (Right to Buy)

Ticker

VIR

Shares

16.0K

Price per share

$0

Execution date (reported)

Oct 27, 2026

Owned after transaction

16.0K shares

Days from execution to publication

1

What this establishes

Topalian Suzanne Louise filed this Form 4 reporting a grant or award of VIR on Oct 27, 2026. It became public on Oct 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Topalian Suzanne Louisecik:0002159860

Issuer

Vir Biotechnology, Inc.cik:0001706431

Revision history · 0

No field has changed since this record was first ingested.